PGF(2alpha)-induced contraction of cat esophageal and lower esophageal sphincter circular smooth muscle.
Lower esophageal sphincter (LES) tone depends on PGF(2alpha) and thromboxane A(2) acting on receptors linked to G(i3) and G(q) to activate phospholipases and produce second messengers resulting in muscle contraction. We therefore examined PGF(2alpha) signal transduction in circular smooth muscle cells isolated by enzymatic digestion from cat esophagus (Eso) and LES. In Eso, PGF(2alpha)-induced contraction was inhibited by antibodies against the alpha-subunit of G(13) and the monomeric G proteins RhoA and ADP-ribosylation factor (ARF)1 and by the C3 exoenzyme of Clostridium botulinum. A [(35)S]GTPgammaS-binding assay confirmed that G(13), RhoA, and ARF1 were activated by PGF(2alpha). Contraction of Eso was reduced by propranolol, a phospholipase D (PLD) pathway inhibitor and by chelerythrine, a PKC inhibitor. In LES, PGF(2alpha)-induced contraction was inhibited by antibodies against the alpha-subunit of G(q) and G(i3), and a [(35)S]GTPgammaS-binding assay confirmed that G(q) and G(i3) were activated by PGF(2alpha). PGF(2alpha)-induced contraction of LES was reduced by U-73122 and D609 and unaffected by propranolol. At low PGF(2alpha) concentration, contraction was blocked by chelerythrine, whereas at high concentration, contraction was blocked by chelerythrine and CGS9343B. Thus, in Eso, PGF(2alpha) activates a PLD- and protein kinase C (PKC)-dependent pathway through G(13), RhoA, and ARF1. In LES, PGF(2alpha) receptors are coupled to G(q) and G(i3), activating phosphatidylinositol- and phosphatidylcholine-specific phospholipase C. At low concentrations, PGF(2alpha) activates PKC. At high concentration, it activates both a PKC- and a calmodulin-dependent pathway.
Cao
Weibiao
W
Department of Medicine, Rhode Island Hospital and Brown University School of Medicine, Providence 02903, USA.
Harnett
Karen M
KM
Behar
Jose
J
Biancani
Piero
P
D000818:Animals; D002147:Calmodulin / Q000502:physiology; D002415:Cats; D015237:Dinoprost / Q000494:pharmacology*; D004943:Esophagogastric Junction / Q000187:drug effects* / Q000502:physiology; D004947:Esophagus / Q000187:drug effects* / Q000502:physiology*; D019204:GTP-Binding Proteins / Q000502:physiology; D008297:Male; D009130:Muscle, Smooth / Q000187:drug effects* / Q000502:physiology; D010528:Peristalsis; D010740:Phospholipases / Q000502:physiology; D011493:Protein Kinase C / Q000502:physiology
D002147:Calmodulin; D015237:Dinoprost; D011493:Protein Kinase C; D010740:Phospholipases; D019204:GTP-Binding Proteins